Leading independent provider of integrated drug discovery resource and expertise.
245 First Street, Cambridge, Massachusetts 02142, US
Sygnature Discovery is a leading contract research organisation (CRO) specialising in drug discovery and pre-clinical development services. Their core mission is to support pharmaceutical and biotechnology companies in accelerating the development of new medicines. Sygnature Discovery offers a wide range of scientific expertise and innovative technologies to identify, design, and develop potential drug candidates. Their purpose is to drive advancements in healthcare by aiding in the discovery of novel therapies for various diseases. Through their research and collaboration with clients, they strive to contribute to the development of safe and effective treatments, ultimately improving the quality of life for patients worldwide.
navigation.benefits
Generous Pension Contributions
Private Medical Insurance
Training and Development opportunities